Loading organizations...
Loading organizations...
Immunotherapy drug research and development for cancer treatment.
ITabMed has raised $20.0M across 1 funding round.
ITabMed has raised $20.0M in total across 1 funding round.
ITabMed has raised $20.0M in total across 1 funding round.
ITabMed's investors include Karen Liu, Wen Chen, Binhai Venture Capital.
ITabMed has raised $20.0M across 1 funding round. Most recently, it raised $20.0M Series A in December 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2021 | $20.0M Series A | Karen Liu, Wen Chen | Binhai Venture Capital |